Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TELI Pharmaceuticals
Melbourne, Victoria, Australia
- Ownership
- Public · TLX
- Employees
- ~400
- Development stage
- Other
01
Overview
Telix has commercial approval for its prostate cancer imaging agent Illuccix® (68Ga-PSMA-11), late-stage programs in prostate, kidney, and brain cancers, and a growing pipeline including alpha-emitting therapeutic and FAP-targeting candidates. Key assets are in global regulatory submissions and pivotal trials with strong diagnostic and therapeutic efficacy and safety profiles[2][6].
- Therapeutic areas
- OncologyHematologyInfectious Diseases
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateRadiopharmaceuticalAlpha-emitting radiopharmaceuticalDiagnostic radiopharmaceuticalProtein
- Industry
- Biotech
02
Partnerships
R2PHARMA (Brazil JV for manufacturing and distribution)ImaginAb (acquisition and access to biologics engineering technology)Lightpoint Medical (medical devices/software)
Beyond the preview
Go deeper on TELI Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TELI Pharmaceuticals.